- Revenue: Not disclosed for QQ2 2023 (No revenue line reported in the quarter data).
- Profitability: Operating income and net income are negative at -$3.195 million; EPS -$0.0532 for Q2 2023.
- R&D/SG&A mix: R&D $1.878 million; SG&A $1.316 million; total operating expenses $3.1947 million.
- Cash flow: Net cash provided by operating activities $2,250; Free cash flow $2,250; cash at period end $2,680; operating cash flow yield per share effectively near zero given small cash base.
- Balance sheet: Total assets $539,148; total liabilities $199,494; cash & equivalents $2,680; total stockholders’ equity $339,654; retained earnings negative at -$31,007,768; short-term debt $12,988; net debt $10,308.
- Liquidity/solvency: Current ratio 2.64; quick ratio 2.58; cash ratio 0.013; interest coverage negative (~-4,049x) signaling minimal near-term debt capacity against negative earnings.
- Valuation signals: Price-to-book and earnings metrics imply an unusual, potentially distorted valuation profile (e.g., price-to-book around 362; negative earnings P/E).
- Net cash burn risk: With negative net income and a tiny cash balance, liquidity runway is a key near-term risk.